Hepatican Ltd Invited to Speak at AMC 2025: Shaping the Future of Advanced Therapy Manufacturing
Professor Barry Fuller invited to speak at IIR Cryogenics 2025 about the challenges of Cryopreservation at Large Scale

Advances in Cryopreservation Enables Rapid, Scalable Liver Cell Therapy for Acute Liver Failure

NIHR Awards Funding for HepatiCan Bioartificial Liver Device to Advance Toward Clinical Trials
